decision tree for Child Life: Four training sessions on decision tree for Child Life were conducted for Child Life Specialists. The training content was produced by the research team based on previous literature and clinical experience. After the training, Child Life Specialists will apply the Child Life decision tree in clinical practice to carry out Child Life intervention.
Routine Child Life intervention for children: Child Life Specialists will conduct Child Life intervention for children based on their professional knowledge and clinical experience in clinical practice.
The purpose of this study is to understand whether the decision tree for Child Life is effective in improving the professional level and working effect of Child Life Specialists. The main questions it aims to answer are:
1. Does the decision tree for Child Life enhance the professional knowledge level of Child Life Specialists?
2. Has the decision tree for Child Life improved the work effectiveness of Child Life Specialists?
3. Has the application of Child Life decision trees improved children's pain levels and compliance?
Researchers will compare the intervention group and the observation group to see if the decision tree for Child Life can enhance the professional level and work effectiveness of Child Life Specialists.
Participants in the intervention group will:
1. Receive training on the application of decision trees for Child Life.
2. Apply the decision tree for Child Life to carry out intervention in Child Life intervention.
3. Participate in knowledge level tests, work effect evaluations, and record the pain levels and compliance of pediatric patients.
Participants in active comparator will:
1. Conduct Child Life intervention based on one's own experience and professional level.
2. Participate in knowledge level tests, work effect evaluations, and record the pain levels and compliance of pediatric patients.
| Facility | City | Region | Status |
|---|---|---|---|
| Children's Hospital of Fudan University | Shanghai | China |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07325890 on ClinicalTrials.gov ↗ ← All trials in China